Clinical Trial: Chemoprevention of Gastric Carcinogenesis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Targeted Chemoprevention of Gastric Carcinogenesis in High Risk Populations

Brief Summary: A clinical study of the efficacy of oral alpha-difluoromethylornithine (eflornithine or DFMO) in male and female subjects ages 30-60 with gastric premalignant lesions in two high risk regions of Latin America.